35 completed, 8 unknown, 4 terminated, 3 withdrawn. 12 Phase 2, 5 Not applicable, 5 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Completed 6, Unknown 3, Terminated 2, Withdrawn 1 |
| Not applicable | 5 | Completed 4, Unknown 1 |
| Phase 1 | 5 | Completed 4, Withdrawn 1 |
| Phase 3 | 2 | Unknown 2 |
Follow Proteomic profiling: new trials by email Literature Review of Proteomic profiling trials Research Report on Proteomic profiling
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Validation of the Proteomic Profiling as a Diagnostic Test for Extra-hepatic Cholangiocarcinoma Proteomic profiling - Cholangiocarcinoma | Not yet recruiting | University Hospital, Bordeaux | 60 | 2025-11-01 | 2025-06-29 | |
| Proteomic Profiling to Differentiate Pancreatic and Biliary Adenocarcinomas proteomic profiling - Pancreatic Adenocarcinoma | Not yet recruiting | University Hospital, Bordeaux | 28 | 2025-09-01 | 2025-06-29 | |
| Multi-omics Analyses on Etiology and Early Detection of Stomach Cancer Precursor Lesions Metabolomic profiling - Chronic Atrophic Gastritis | Active not recruiting | Karolinska Institutet | 12599 | 2024-01-01 | 2024-02-21 | |
| Hepatobiliary Tumors Tissue Samples Acquisition Gene expression analysis, Genomic analysis, Protein expression analysis - Hepatocellular Carcinoma, Cholangiocarcinoma | Unknown | Peking Union Medical College Hospital | 450 | 2020-10-11 | 2023-07-07 | |
| Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia RNA analysis, proteomic profiling, laboratory biomarker analysis - Leukemia | Completed | Children's Oncology Group | 20 | 2012-05-01 | 2016-05-17 | |
| Biomarkers in Urine Samples From Patients With Wilms Tumor proteomic profiling, enzyme-linked immunosorbent assay, laboratory biomarker analysis - Kidney Cancer | Completed | Children's Oncology Group | 100 | 2012-03-01 | 2016-07-11 | |
| Studying Biomarkers in Samples From Younger Patients With Wilms Tumor gene expression analysis, proteomic profiling, reverse transcriptase-polymerase chain reaction - Kidney Cancer | Completed | Children's Oncology Group | 20 | 2012-02-01 | 2016-05-18 | |
| Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma RNA analysis, polymerase chain reaction, protein expression analysis - Neuroblastoma | Completed | Children's Oncology Group | 300 | 2011-06-01 | 2016-05-18 | |
| S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy proteomic profiling, flow cytometry, laboratory biomarker analysis - Leukemia | Completed | SWOG Cancer Research Network | 310 | 2011-06-01 | 2016-04-15 | |
| S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia gene expression analysis, proteomic profiling, flow cytometry - Leukemia | Completed | SWOG Cancer Research Network | 290 | 2011-03-01 | 2015-03-06 | |
| Biomarkers in Bone Marrow and Blood Samples From Older Patients With Acute Myeloid Leukemia Treated With Cytarabine-Based Therapy proteomic profiling, flow cytometry, laboratory biomarker analysis - Leukemia | Completed | ECOG-ACRIN Cancer Research Group | 200 | 2010-07-08 | 2017-05-17 | |
| Studying Biomarkers in Blood Samples From Patients With Invasive Cervical Cancer proteomic profiling, laboratory biomarker analysis - Cervical Cancer | Unknown | Gynecologic Oncology Group | 84 | 2010-02-01 | 2010-02-24 | |
| Temozolomide in Treating Patients With Invasive Pituitary Tumors temozolomide, DNA methylation analysis, microarray analysis - Brain and Central Nervous System Tumors | Phase 2 | Withdrawn | Jonsson Comprehensive Cancer Center | 2009-12-01 | 2020-07-31 | |
| Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421 gene expression analysis, microarray analysis, proteomic profiling - Leukemia | Completed | Children's Oncology Group | 90 | 2009-10-01 | 2016-05-18 | |
| ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme temozolomide, veliparib, DNA methylation analysis - Brain and Central Nervous System Tumors | Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 24 | 2009-07-13 | 2018-06-27 |
| Study of Biomarkers in Blood & Tissue Samples From Patients With Colorectal Cancer or Polyps & Patients Without Polyps gene expression analysis, polymerase chain reaction, polymorphism analysis - Colorectal Cancer, Healthy, no Evidence of Disease | Completed | Indiana University | 551 | 2009-01-01 | 2014-09-18 | |
| Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment rituximab, bortezomib, pegylated liposomal doxorubicin hydrochloride - Lymphoma | Phase 2 | Terminated | Roswell Park Cancer Institute | 9 | 2009-01-01 | 2014-07-21 |
| S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors docetaxel, vandetanib, proteomic profiling - Breast Cancer, Head and Neck Cancer | Phase 1 | Withdrawn | SWOG Cancer Research Network | 2008-09-01 | 2017-04-24 | |
| Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer SOD1 inhibitor ATN-224, exemestane, protein expression analysis - Breast Cancer | Phase 2 | Terminated | Cancer Research UK | 111 | 2008-06-01 | 2013-07-10 |
| Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants proteomic profiling, biologic sample preservation procedure, laboratory biomarker analysis - Healthy, no Evidence of Disease, Lung Cancer | Completed | Vanderbilt-Ingram Cancer Center | 37 | 2008-04-01 | 2014-06-24 |
Showing 20 of 53. Sign in to see all of them.
Breast Neoplasms (10) · Carcinoma, Non-Small-Cell Lung (7) · Lung Neoplasms (7) · Leukemia (6) · Prostatic Neoplasms (5) · Colonic Neoplasms (4) · Lymphoma (4) · Rectal Neoplasms (4) · Colorectal Neoplasms (3) · Congenital Abnormalities (3) · Leukemia, Erythroblastic, Acute (3) · Leukemia, Megakaryoblastic, Acute (3) · Leukemia, Monocytic, Acute (3) · Leukemia, Myeloid, Acute (3) · Leukemia, Myelomonocytic, Acute (3)
Vanderbilt-Ingram Cancer Center (7) · Children's Oncology Group (5) · City of Hope Medical Center (3) · ECOG-ACRIN Cancer Research Group (3) · National Institutes of Health Clinical Center (CC) (3) · SWOG Cancer Research Network (3) · Gynecologic Oncology Group (2) · Memorial Sloan Kettering Cancer Center (2) · Royal Marsden NHS Foundation Trust (2) · University Hospital, Bordeaux (2) · University of California, San Francisco (2) · Alliance for Clinical Trials in Oncology (1) · Barbara Ann Karmanos Cancer Institute (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Cancer Research UK (1)
United States (22) · United Kingdom (5) · France (3) · Canada (1) · China (1) · Ireland (1) · Italy (1) · Sweden (1)
Gerald Gui, MD, MS, FRCS(Edin), FRCS(Eng) (2) · Jerry Radich, MD (2) · Mark C. Udey, MD, PhD (2) · Pierre P. Massion, MD (2) · Samir N. Khleif, MD (2) · A. Bapsi Chakravarthy, MD (1) · Adrian L. Harris, MD (1) · Allen E. Bale, MD (1) · Anil Wali, PhD (1) · Anthony Heaney, MD (1) · David Carbone, M.D., Ph.D. (1) · David H. Harpole, MD (1) · David H. Ilson, MD, PhD (1) · David P. Carbone, MD, PhD (1) · Eileen O'Reilly, MD (1)
PMID 24383844, PMID 25527568, PMID 17854367, PMID 18799354, PMID 24831979, PMID 24901360
P30CA068485 (6), P30CA033572 (2), U10CA032102 (2), 2023 (1), P30CA008748 (1), P30CA022453 (1), P30CA082709 (1), P30CA093373 (1), P50CA090949 (1), U01CA062475 (1)